In addition, NRAS mutations, which are associated with signaling pathways and a poor prognosis, are frequently observed in secondary AML [8].The gene mutations frequently observed in the current study are considered to reflect the profile of elderly high-risk AML patients. The gene discussed is NRAS; the disease is acute myeloid leukemia.